Persisters—as elusive as ever

Applied Microbiology and Biotechnology

Volumn 100, Issue 15, 2016, Pages 6545-6553

  Kaldalu, Niilo ^a   Hauryliuk, Vasili ^a,b   Tenson, Tanel ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Antibiotic development; Antibiotic resistance; Antibiotic tolerance; Bacterial infections; Bet hedging; Persisters

Indexed keywords

BIOLOGY; BIOTECHNOLOGY;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC TOLERANCES; BACTERIAL INFECTIONS; BET HEDGING; PERSISTERS;

ANTIBIOTICS;

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; DRUG; GROWTH RATE; GROWTH RESPONSE; HETEROGENEITY; PERSISTENCE; PHYSIOLOGICAL RESPONSE;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM CULTURE; NONHUMAN; RECURRENT INFECTION; REVIEW; BACTERIAL INFECTIONS; BIOFILM; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; MULTIDRUG RESISTANCE; RECURRENT DISEASE;

BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOFILMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; RECURRENCE;

EID: 84978168312     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-016-7648-8     Document Type: Review

References (104)

1. Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, Edelstein PH, Cosma CL, Ramakrishnan L (2011) Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39–53. doi:10.1016/j.cell.2011.02.022
2. Allison KR, Brynildsen MP, Collins JJ (2011a) Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol 14:593–598. doi:10.1016/j.mib.2011.09.002
3. Allison KR, Brynildsen MP, Collins JJ (2011b) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473:216–220. doi:10.1038/nature10069
4. Amato SM, Brynildsen MP (2015) Persister heterogeneity arising from a single metabolic stress. Curr Biol 25:2090–2098. doi:10.1016/j.cub.2015.06.034
5. Amato SM, Brynildsen MP (2014) Nutrient transitions are a source of persisters in Escherichia coli biofilms. PLoS One 9:e93110. doi:10.1371/journal.pone.0093110
6. Amato SM, Fazen CH, Henry TC, Mok WWK, Orman MA, Sandvik EL, Volzing KG, Brynildsen MP (2014) The role of metabolism in bacterial persistence. Front Microbiol 5:70. doi:10.3389/fmicb.2014.00070
7. Amato SM, Orman MA, Brynildsen MP (2013) Metabolic control of persister formation in Escherichia coli. Mol Cell 50:475–487. doi:10.1016/j.molcel.2013.04.002
8. Ayrapetyan M, Williams TC, Baxter R, Oliver JD (2015a) Viable but nonculturable and persister cells coexist stochastically and are induced by human serum. Infect Immun 83:4194–4203. doi:10.1128/IAI.00404-15
9. Ayrapetyan M, Williams TC, Oliver JD (2015b) Bridging the gap between viable but non-culturable and antibiotic persistent bacteria. Trends Microbiol 23:7–13. doi:10.1016/j.tim.2014.09.004
10. Balaban NQ (2011) Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr Opin Genet Dev 21:768–775. doi:10.1016/j.gde.2011.10.001
11. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305:1622–1625. doi:10.1126/science.1099390
12. Bentsink L, Koornneef M (2008) Seed dormancy and germination. Arabidopsis Book 6:e0119. doi:10.1199/tab.0119
13. Bergmiller T, Ackermann M, Silander OK (2012) Patterns of evolutionary conservation of essential genes correlate with their compensability. PLoS Genet 8:e1002803. doi:10.1371/journal.pgen.1002803
14. Bianchi A, Giuliano L (1996) Enumeration of viable bacteria in the marine pelagic environment. Appl Environ Microbiol 62:174–177
15. Bigger J (1944) Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 244:497–500. doi:10.1016/S0140-6736(00)74210-3
16. Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV (2014) Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13:42–51. doi:10.1038/nrmicro3380
17. Brauner A, Fridman O, Gefen O, Balaban NQ (2016) Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14:320–330. doi:10.1038/nrmicro.2016.34
18. Cañas-Duarte SJ, Restrepo S, Pedraza JM (2014) Novel protocol for persister cells isolation. PLoS One 9:e88660. doi:10.1371/journal.pone.0088660
19. Chowdhury N, Kwan BW, Wood TK (2016) Persistence increases in the absence of the alarmone guanosine tetraphosphate by reducing cell growth. Sci Rep 6:20519. doi:10.1038/srep20519
20. Claudi B, Spröte P, Chirkova A, Personnic N, Zankl J, Schürmann N, Schmidt A, Bumann D (2014) Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell 158:722–733. doi:10.1016/j.cell.2014.06.045
21. Cohen NR, Lobritz MA, Collins JJ (2013) Microbial persistence and the road to drug resistance. Cell Host Microbe 13:632–42. doi:10.1016/j.chom.2013.05.009
22. Conlon BP, Nakayasu ES, Fleck LE, LaFleur MD, Isabella VM, Coleman K, Leonard SN, Smith RD, Adkins JN, Lewis K (2013) Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503:365–370. doi:10.1038/nature12790
23. Conlon BP, Rowe SE, Gandt AB, Nuxoll AS, Donegan NP, Zalis EA, Clair G, Adkins JN, Cheung AL, Lewis K (2016) Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol 1:16051. doi:10.1038/nmicrobiol.2016.51
24. De Groote VN, Verstraeten N, Fauvart M, Kint CI, Verbeeck AM, Beullens S, Cornelis P, Michiels J (2009) Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol Lett 297:73–79. doi:10.1111/j.1574-6968.2009.01657.x
25. de Jong IG, Haccou P, Kuipers OP (2011) Bet hedging or not? A guide to proper classification of microbial survival strategies. BioEssays 33:215–223. doi:10.1002/bies.201000127
26. Desmonts C, Minet J, Colwell R, Cormier M (1990) Fluorescent-antibody method useful for detecting viable but nonculturable Salmonella spp. in chlorinated wastewater. Appl Environ Microbiol 56:1448–1452
27. Dörr T, Lewis K, Vulić M (2009) SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet 5:e1000760. doi:10.1371/journal.pgen.1000760
28. Dörr T, Vulić M, Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8:e1000317. doi:10.1371/journal.pbio.1000317
29. Gao W, Chua K, Davies JK, Newton HJ, Seemann T, Harrison PF, Holmes NE, Rhee H-W, Hong J-I, Hartland EL, Stinear TP, Howden BP (2010) Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog 6:e1000944. doi:10.1371/journal.ppat.1000944
30. Gerdes K, Maisonneuve E (2012) Bacterial persistence and toxin-antitoxin loci. Annu Rev Microbiol 66:103–123. doi:10.1146/annurev-micro-092611-150159
31. Girgis HS, Harris K, Tavazoie S (2012) Large mutational target size for rapid emergence of bacterial persistence. Proc Natl Acad Sci U S A 109:12740–12745. doi:10.1073/pnas.1205124109
32. Goneau LW, Yeoh NS, MacDonald KW, Cadieux PA, Burton JP, Razvi H, Reid G (2014) Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrob Agents Chemother 58:2089–2097. doi:10.1128/AAC.02552-13
33. González-Pastor JE (2011) Cannibalism: a social behavior in sporulating Bacillus subtilis. FEMS Microbiol Rev 35:415–424. doi:10.1111/j.1574-6976.2010.00253.x
34. Grimbergen AJ, Siebring J, Solopova A, Kuipers OP (2015) Microbial bet-hedging: the power of being different. Curr Opin Microbiol 25:67–72. doi:10.1016/j.mib.2015.04.008
35. Hansen S, Lewis K, Vulić M (2008) Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother 52:2718–2726. doi:10.1128/AAC.00144-08
36. Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW (2014) Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343:204–208. doi:10.1126/science.1244705
37. Johnson PJT, Levin BR (2013) Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet 9:e1003123. doi:10.1371/journal.pgen.1003123
38. Jõers A, Kaldalu N, Tenson T (2010) The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J Bacteriol 192:3379–3384. doi:10.1128/JB.00056-10
39. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K (2004a) Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230:13–18
40. Keren I, Minami S, Rubin E, Lewis K (2011) Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio 2:e00100–e00111. doi:10.1128/mBio.00100-11
41. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004b) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186:8172–8180. doi:10.1128/JB.186.24.8172
42. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K (2013) Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339:1213–1216. doi:10.1126/science.1232688
43. Kester JC, Fortune SM (2014) Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria. Crit Rev Biochem Mol Biol 49:91–101. doi:10.3109/10409238.2013.869543
44. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797–810. doi:10.1016/j.cell.2007.06.049
45. Kotte O, Volkmer B, Radzikowski JL, Heinemann M (2014) Phenotypic bistability in Escherichia coli’s central carbon metabolism. Mol Syst Biol 10:736. doi:10.15252/msb.20135022
46. Lafleur MD, Qi Q, Lewis K (2010) Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother 54:39–44. doi:10.1128/AAC.00860-09
47. Lechner S, Lewis K, Bertram R (2012) Staphylococcus aureus persisters tolerant to bactericidal antibiotics. J Mol Microbiol Biotechnol 22:235–244. doi:10.1159/000342449
48. Leimer N, Rachmühl C, Palheiros Marques M, Bahlmann AS, Furrer A, Eichenseher F, Seidl K, Matt U, Loessner MJ, Schuepbach RA, Zinkernagel AS (2016) Nonstable Staphylococcus aureus small-colony variants are induced by low pH and sensitized to antimicrobial therapy by phagolysosomal alkalinization. J Infect Dis 213:305–313. doi:10.1093/infdis/jiv388
49. Lenski RE, Mongold JA, Sniegowski PD, Travisano M, Vasi F, Gerrish PJ, Schmidt TM (1998) Evolution of competitive fitness in experimental populations of E. coli: what makes one genotype a better competitor than another? Antonie Van Leeuwenhoek 73:35–47
50. Levin BR, Concepción-Acevedo J, Udekwu KI (2014) Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics. Curr Opin Microbiol 21:18–21. doi:10.1016/j.mib.2014.06.016
51. Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45:999–1007. doi:10.1128/AAC.45.4.999-1007.2001
52. Lewis K (2010) Persister cells. Annu Rev Microbiol 64:357–372. doi:10.1146/annurev.micro.112408.134306
53. Li L, Mendis N, Trigui H, Oliver JD, Faucher SP (2014) The importance of the viable but non-culturable state in human bacterial pathogens. Front Microbiol 5:258. doi:10.3389/fmicb.2014.00258
54. Li Y, Zhang Y (2007) PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother 51:2092–2099. doi:10.1128/AAC.00052-07
55. Liu Y, Imlay JA (2013) Cell death from antibiotics without the involvement of reactive oxygen species. Science 339:1210–1213. doi:10.1126/science.1232751
56. Luidalepp H, Jõers A, Kaldalu N, Tenson T (2011) Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J Bacteriol 193:3598–3605. doi:10.1128/JB.00085-11
57. Madar D, Dekel E, Bren A, Zimmer A, Porat Z, Alon U (2013) Promoter activity dynamics in the lag phase of Escherichia coli. BMC Syst Biol 7:136. doi:10.1186/1752-0509-7-136
58. Maisonneuve E, Castro-Camargo M, Gerdes K (2013) (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 154:1140–1150. doi:10.1016/j.cell.2013.07.048
59. Maisonneuve E, Gerdes K (2014) Molecular mechanisms underlying bacterial persisters. Cell 157:539–548. doi:10.1016/j.cell.2014.02.050
60. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K (2011) Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A 108:13206–13211. doi:10.1073/pnas.1100186108
61. Makarova KS, Wolf YI, Koonin EV (2009) Comprehensive comparative-genomic analysis of type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes. Biol Direct 4:19. doi:10.1186/1745-6150-4-19
62. McDermott W (1958) Microbial persistence. Yale J Biol Med 30:257–291
63. Meyer K, Chaffee E, Hobby GL, Dawson MH, Schwenk E, Fleischer G (1942) On penicillin. Science 96:20–21. doi:10.1126/science.96.2479.20
64. Mok WWK, Park JO, Rabinowitz JD, Brynildsen MP (2015) RNA futile cycling in model persisters derived from MazF accumulation. MBio 6:e01588–e01515. doi:10.1128/mBio.01588-15
65. Montero M, Rahimpour M, Viale AM, Almagro G, Eydallin G, Sevilla Á, Cánovas M, Bernal C, Lozano AB, Muñoz FJ, Baroja-Fernández E, Bahaji A, Mori H, Codoñer FM, Pozueta-Romero J (2014a) Systematic production of inactivating and non-inactivating suppressor mutations at the relA locus that compensate the detrimental effects of complete spot loss and affect glycogen content in Escherichia coli. PLoS One 9:e106938. doi:10.1371/journal.pone.0106938
66. Moyed HS, Bertrand KP (1983) hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155:768–775
67. Mulcahy LR, Burns JL, Lory S, Lewis K (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192:6191–6199. doi:10.1128/JB.01651-09
68. Neidhardt FC (2006) Apples, oranges and unknown fruit. Nat Rev Microbiol 4:876. doi:10.1038/nrmicro1554
69. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, McKay G, Siehnel R, Schafhauser J, Wang Y, Britigan BE, Singh PK (2011) Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334:982–986. doi:10.1126/science.1211037
70. Norton JP, Mulvey MA (2012) Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli. PLoS Pathog 8:e1002954. doi:10.1371/journal.ppat.1002954
71. Nyström T, Gustavsson N (1998) Maintenance energy requirement: what is required for stasis survival of Escherichia coli? Biochim Biophys Acta 1365:225–231
72. Ocampo PS, Lázár V, Papp B, Arnoldini M, Abel zur Wiesch P, Busa-Fekete R, Fekete G, Pál C, Ackermann M, Bonhoeffer S (2014) Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrob Agents Chemother 58:4573–4582. doi:10.1128/AAC.02463-14
73. Oliver JD (2010) Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol Rev 34:415–425. doi:10.1111/j.1574-6976.2009.00200.x
74. Palmer AC, Kishony R (2013) Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat Rev Genet 14:243–248. doi:10.1038/nrg3351
75. Pandey DP, Gerdes K (2005) Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res 33:966–976. doi:10.1093/nar/gki201
76. Pinto D, Santos MA, Chambel L (2015) Thirty years of viable but nonculturable state research: unsolved molecular mechanisms. Crit. Rev. Microbiol. 41:61-76. doi:10.3109/1040841X.2013.794127
77. Pu Y, Zhao Z, Li Y, Zou J, Ma Q, Zhao Y, Ke Y, Zhu Y, Chen H, Baker MAB, Ge H, Sun Y, Xie XS, Bai F (2016) Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol Cell 62:284–294. doi:10.1016/j.molcel.2016.03.035
78. Rappé MS, Giovannoni SJ (2003) The uncultured microbial majority. Annu Rev Microbiol 57:369–394. doi:10.1146/annurev.micro.57.030502.090759
79. Roostalu J, Jõers A, Luidalepp H, Kaldalu N, Tenson T (2008) Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol 8:68. doi:10.1186/1471-2180-8-68
80. Rotem E, Loinger A, Ronin I, Levin-Reisman I, Gabay C, Shoresh N, Biham O, Balaban NQ (2010) Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc Natl Acad Sci U S A 107:12541–12546. doi:10.1073/pnas.1004333107
81. Sarath G, Baird LM, Mitchell RB (2014) Senescence, dormancy and tillering in perennial C4 grasses. Plant Sci 217-218:140–151. doi:10.1016/j.plantsci.2013.12.012
82. Schumacher MA, Balani P, Min J, Chinnam NB, Hansen S, Vulić M, Lewis K, Brennan RG (2015) HipBA-promoter structures reveal the basis of heritable multidrug tolerance. Nature 524:59–64. doi:10.1038/nature14662
83. Shachrai I, Zaslaver A, Alon U, Dekel E (2011) Cost of unneeded proteins in E. coli is reduced after several generations in exponential growth. Mol Cell 42:401. doi:10.1016/j.molcel.2011.04.009
84. Shachrai I, Zaslaver A, Alon U, Dekel E (2010) Cost of unneeded proteins in E. coli is reduced after several generations in exponential growth. Mol Cell 38:758–767. doi:10.1016/j.molcel.2010.04.015
85. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K (2006) Persisters: a distinct physiological state of E. coli. BMC Microbiol 6:53. doi:10.1186/1471-2180-6-53
86. Shan Y, Lazinski D, Rowe S, Camilli A, Lewis K (2015) Genetic basis of persister tolerance to aminoglycosides in Escherichia coli. MBio. doi:10.1128/mBio.00078-15
87. Spoering AL, Lewis K (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 183:6746–6751. doi:10.1128/JB.183.23.6746-6751.2001
88. Spoering AL, Vulic M, Lewis K (2006) GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol 188:5136–5144. doi:10.1128/JB.00369-06
89. Sturm A, Dworkin J (2015) Phenotypic diversity as a mechanism to exit cellular dormancy. Curr Biol 25:2272–2277. doi:10.1016/j.cub.2015.07.018
90. Theodore A, Lewis K, Vulic M (2013) Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway. Genetics 195:1265–1276. doi:10.1534/genetics.113.152306
91. Tomasz A, Albino A, Zanati E (1970) Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 227:138–140. doi:10.1038/227138a0
92. Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A (1986a) The rate of killing of Escherichia coli by β-lactam antibiotics is strictly proportional to the rate of bacterial growth. Microbiology 132:1297–1304. doi:10.1099/00221287-132-5-1297
93. Tuomanen E, Durack DT, Tomasz A (1986b) Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother 30:521–527
94. Van den Bergh B, Michiels JE, Wenseleers T, Windels EM, Vanden BP, Kestemont D, De Meester L, KJ V, Verstraeten N, Fauvart M, Michiels J (2016) Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat Microbiol 1:16020. doi:10.1038/nmicrobiol.2016.20
95. Varik V, Oliveira SRA, Hauryliuk V, Tenson T (2016) Composition of the outgrowth medium modulates wake-up kinetics and ampicillin sensitivity of stringent and relaxed Escherichia coli. Sci Rep 6:22308. doi:10.1038/srep22308
96. Vázquez-Laslop N, Lee H, Neyfakh AA (2006) Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol 188:3494–3497. doi:10.1128/JB.188.10.3494-3497.2006
97. Verplaetse E, Slamti L, Gohar M, Lereclus D (2015) Cell differentiation in a Bacillus thuringiensis population during planktonic growth, biofilm formation, and host infection. MBio 6:e00138–e00115. doi:10.1128/mBio.00138-15
98. Verstraeten N, Knapen WJ, Kint CI, Liebens V, Van den Bergh B, Dewachter L, Michiels JE, Fu Q, David CC, Fierro AC, Marchal K, Beirlant J, Versées W, Hofkens J, Jansen M, Fauvart M, Michiels J (2015) Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance. Mol Cell 59:9–21. doi:10.1016/j.molcel.2015.05.011
99. Wakamoto Y, Dhar N, Chait R, Schneider K, Signorino-Gelo F, Leibler S, McKinney JD (2013) Dynamic persistence of antibiotic-stressed mycobacteria. Science 339:91–95. doi:10.1126/science.1229858
100. Wilson DN (2014) Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol 12:35–48. doi:10.1038/nrmicro3155
101. Wolfson JS, Hooper DC, McHugh GL, Bozza MA, Swartz MN (1990) Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents. Antimicrob Agents Chemother 34:1938–1943. doi:10.1128/AAC.34.10.1938
102. Wu Y, Vulić M, Keren I, Lewis K (2012) Role of oxidative stress in persister tolerance. Antimicrob Agents Chemother 56:4922–4926. doi:10.1128/AAC.00921-12
103. Xiao H, Kalman M, Ikehara K, Zemel S, Glaser G, Cashel M (1991) Residual guanosine 3′,5′-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations. J Biol Chem 266:5980–5990
104. Xu HS, Roberts N, Singleton FL, Attwell RW, Grimes DJ, Colwell RR (1982) Survival and viability of nonculturable Escherichia coli and Vibrio cholerae in the estuarine and marine environment. Microb Ecol 8:313–323. doi:10.1007/BF02010671